The optimal cut‐off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi‐institutional study

Despite the long‐standing consensus on the importance of tumor size, tumor number and carcinoembryonic antigen (CEA) levels as predictors of long‐term outcomes among patients with colorectal liver metastases (CRLM), optimal prognostic cut‐offs for these variables have not been established.

[1]  M. Brennan,et al.  Predicting Survival in Colorectal Liver Metastasis: Time for New Approaches , 2020, Annals of Surgical Oncology.

[2]  P. Lønning,et al.  The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status , 2019, Annals of surgery.

[3]  I. Endo,et al.  KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[4]  Yuhree Kim,et al.  Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases , 2018, The British journal of surgery.

[5]  P. Lønning,et al.  Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer , 2018, JAMA surgery.

[6]  P. Lønning,et al.  Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients. , 2018, Annals of surgery.

[7]  C. Compton,et al.  Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes , 2017, Journal of surgical oncology.

[8]  O. Lichtarge,et al.  Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases , 2017, Annals of surgery.

[9]  J. Shindoh,et al.  RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases , 2017, Annals of surgery.

[10]  C. Punt,et al.  Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: A case‐matched comparison with palliative systemic therapy , 2017, Surgery.

[11]  J. Vauthey,et al.  Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection , 2017, Surgery.

[12]  J. Vauthey,et al.  Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases , 2016, Annals of surgery.

[13]  T. Pawlik,et al.  Pre-hepatectomy carcinoembryonic antigen (CEA) levels among patients undergoing resection of colorectal liver metastases: do CEA levels still have prognostic implications? , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[14]  S. Barni,et al.  Prognostic factors after R0 resection of colorectal cancer liver metastases: A systematic review and pooled-analysis. , 2016, Reviews on recent clinical trials.

[15]  William R Jarnagin,et al.  Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? , 2015, Annals of surgery.

[16]  M. Choti,et al.  Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases , 2015, Annals of Surgical Oncology.

[17]  C. Punt,et al.  Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group , 2015, The Lancet.

[18]  Steven A. Curley,et al.  RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases , 2013, Annals of surgery.

[19]  R. Charnley,et al.  Prognostic Factors and Survival after Resection of Colorectal Liver Metastasis in the Era of Preoperative Chemotherapy: An 11-Year Single-Centre Study , 2013, Digestive Surgery.

[20]  W. Ye,et al.  Outcome of Patients with Colorectal Liver Metastasis: Analysis of 1,613 Consecutive Cases , 2012, Annals of Surgical Oncology.

[21]  T. Misawa,et al.  Carcinoembryonic antigen and carbohydrate antigen 19-9 are prognostic predictors of colorectal cancer with unresectable liver metastasis. , 2012, Oncology letters.

[22]  P. Colombo,et al.  Is Perioperative Chemotherapy Useful for Solitary, Metachronous, Colorectal Liver Metastases? , 2010, Annals of surgery.

[23]  J. McCall,et al.  Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases , 2009, The British journal of surgery.

[24]  H. Saeger,et al.  Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[25]  R. Adam,et al.  R1 Resection by Necessity for Colorectal Liver Metastases: Is It Still a Contraindication to Surgery? , 2008, Annals of surgery.

[26]  M. Gonen,et al.  Effect of Postoperative Morbidity on Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer , 2008, Annals of surgery.

[27]  P. Tekkis,et al.  Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer: A Multifactorial Model of 929 Patients , 2008, Annals of surgery.

[28]  O. Garden,et al.  Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies , 2006, British Journal of Cancer.

[29]  O. Garden,et al.  Prognostic scoring in colorectal cancer liver metastases: development and validation. , 2005, Archives of surgery.

[30]  Bernard Paule,et al.  Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival , 2004, Annals of surgery.

[31]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[32]  T. Starzl,et al.  Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. , 1999, Journal of the American College of Surgeons.

[33]  B. Nordlinger,et al.  Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients , 1996, Cancer.

[34]  M. Gönen,et al.  Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients. , 2018, Annals of surgery.

[35]  Mithat Gönen,et al.  Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma , 2017, Annals of surgery.

[36]  M. Gönen,et al.  Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection , 2016, Annals of surgery.